Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00755482 · ClinicalTrials.gov registry record · Phase 1

Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee

A Phase 1 study of Osteoarthritis of the Knee, sponsored by Marigot.

Completed
Registry status
Phase 1
Development phase
29
Enrollment target
1
Study location

NCT00755482: Completed Phase 1 study of Osteoarthritis of the Knee, sponsored by Marigot.

NCT00755482 is a Phase 1 study of Osteoarthritis of the Knee that has completed, run by Marigot. The registered enrollment target is 29 participants, below the 211-participant average among 16 other Osteoarthritis of the Knee trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00755482, a Phase 1 study of Osteoarthritis of the Knee, has completed, sponsored by Marigot.

COMPLETED
Registry status
Phase 1
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The objective of this trial is to evaluate the effect of Aquamin F versus placebo on NSAID (non-steroidal anti-inflammatory drug) dose reduction in subjects with osteoarthritis of the knee. Hypothesis 1: After 12 weeks of treatment, subjects taking Aquamin F will use significantly less NSAID medications for symptoms of osteoarthritis versus placebo alone. Hypothesis 2: No significant differences will be seen for adverse events between the subjects taking Aquamin F or placebo.

Conditions Studied

Interventions

  • DRUG Aquamin F
  • DRUG Placebo (maltodextran)

Study Locations (1)

Minnesota

  • Minnesota Applied Research Center - Edina

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2006-01
Est. Completion 2006-09
Phase Phase 1
Marigot

1 total trials

What the finished NCT00755482 record still lists

NCT00755482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 211-participant average among 16 other Osteoarthritis of the Knee trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 2 interventions - of which Aquamin F is the first listed.

NCT00755482 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00755482 about?

NCT00755482 is a clinical study titled "Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee". The objective of this trial is to evaluate the effect of Aquamin F versus placebo on NSAID (non-steroidal anti-inflammatory drug) dose reduction in subjects with osteoarthritis of the knee. Hypothesis 1: After 12 weeks of treatment, subjects taking Aquamin F will use significantly less NSAID medica...

What is the current status of trial NCT00755482?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2006-01. Estimated completion is 2006-09.

What conditions does trial NCT00755482 study?

This clinical trial studies the following conditions: Osteoarthritis of the Knee.

What interventions are being tested in trial NCT00755482?

The interventions under investigation include: Aquamin F (DRUG), Placebo (maltodextran) (DRUG).

Who is sponsoring clinical trial NCT00755482?

This trial is sponsored by Marigot, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00755482 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis of the Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00755482's enrollment target sits among peer trials

29 16th of 16 higher than 1 of 16 other Osteoarthritis of the Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis of the Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00755482, the US trial registry maintained by the National Library of Medicine. NCT00755482 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.